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Summary
Objective: Injury to the anterior cruciate ligament (ACL) frequently leads to post-traumatic osteoarthritis (OA). In this study we determined
whether early degenerative changes characteristic of idiopathic OA are induced in articular cartilage following ACL injury.
Methods: A small sample of femoral articular cartilage was removed at surgery, as part of ACL reconstruction, from a total of 50 patients with
ACL injuries. Of these, 28 underwent surgery less than 1 year post-injury. Control cartilages were obtained from the same site from 21 persons
at autopsy. All cartilages were examined for molecular changes. The content of type II collagen, its cleavage by collagenases and its dena-
turation were determined by immunoassay. The total content of glycosaminoglycan (GAG), which is principally aggrecan, was measured col-
orimetrically. Data were expressed per unit DNA (GAG and collagen content) or as a percentage of total collagen cleaved or denatured. Other
cartilages from the same site (8 controls, 12 less than 1 year and 8 more than 1 year post-injury) were frozen sectioned and examined his-
tologically to determine by Mankin grading cartilage degeneration.
Results: Histological analyses revealed that control subjects exhibited staining for proteoglycan, which was reduced in some patients following
ACL rupture. Degeneration of the articular surface was sometimes observed 1 year after ACL rupture. Although the Mankin grade increased
with time after rupture these changes were not signiﬁcant. Immunoassays, however, revealed an increase in GAG content within 1 year which
was maintained after 1 year although no longer signiﬁcant. No changes in total type II collagen content were observed during the period of
study. However, there were signiﬁcant increases in the denaturation and cleavage of type II collagen less than and more than 1 year post-ACL
rupture. Total type II collagen content was directly correlated with GAG content in all three groups, with the signiﬁcance being weakest at more
than 1 year. After 1 year an inverse correlation was observed between total type II collagen content and collagen cleavage as well as
denaturation.
Conclusions: These observations reveal that joint instability resulting from ACL injury rapidly results in degenerative changes characteristic of
those seen in idiopathic OA at arthroplasty and in experimental OA following ACL surgery. These changes may contribute to the development
of post-traumatic OA that is commonly observed following ACL injury. The observations support and extend conclusions from other studies on
human and animal articular cartilage and synovial ﬂuids post-ACL injury that have revealed a rapid onset of damage to type II collagen and an
initial increase in proteoglycan content characteristic of experimental OA post-ACL injury. This study provides direct evidence for the rapid
development of degenerative changes characteristic of OA following ACL injury.
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Human articular cartilage provides an almost frictionless ar-
ticulation. Idiopathic degenerative changes in this tissue
leading to the development of osteoarthritis (OA) are asso-
ciated with ageing1,2 or may follow traumatic injury to a joint
such as rupture of the anterior cruciate ligament (ACL)2. In
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with increased damage to and loss of type II collagen3e8,
the principle component of the extracellular matrix of articu-
lar cartilage.
Type II collagen is composed of tropocollagen molecules
each of which contains three identical a chains that form
a triple helix. The molecules are organized in a quarter stag-
ger to form ﬁbrils. These endow the tissue with its tensile
strength9,10. The triple helix of type II collagen can be
cleaved by collagenases at a single cleavage site approxi-
mately three quarter distant from the amino terminus. One
can detect this cleavage using antibodies to the carboxyter-
minal neoepitope generated by this initial cleavage7,8,11,12.
Following cleavage, the molecule denatures exposing intra-
chain epitopes that can then be detected by polyclonal4 and
monoclonal5,6 antibodies. Using this technology we have4
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companies the increased denaturation and loss of type II
collagen4,5 in idiopathic OA.
Loss of the proteoglycan aggrecan accompanies local
damage to type II collagen3,6 but initially in animal models
of early OA an increased content of proteoglycan is
observed13.
Immunoassays for aggrecan14,15, type II procollagen C-
propeptide16 and cross-linked peptides of type II collagen17
in synovial ﬂuids of patients taken before and following trau-
matic injury (such as rupture of the ACL), have provided
evidence for the rapid onset of increased release and/or
turnover of these cartilage-speciﬁc molecules following in-
jury. The latter changes persist following injury and are
associated with the development of post-traumatic OA
that is commonly observed following knee injury2.
Injury to the ACL is usually managed by ligament recon-
struction. Part of this procedure involves removal of a small
portion of the adjacent articular cartilage at the lateral notch
of the femur that can then be analysed. By histological and
molecular analyses of this cartilage and comparison with
the same tissue taken at autopsy from uninjured joints,
we show that within a year of ACL injury there is histological
evidence of degeneration and a persistent increase in colla-
genase cleavage and denaturation of type II collagen which
is associated with an early transient increase (within 1 year)
in the total content of proteoglycan (mainly aggrecan). Such
changes are also seen in idiopathic human and experimen-
tal OA. These observations, therefore, suggest that the
onset and development of post-traumatic cartilage degener-
ation is a rapid process that exhibits some of the same fea-
tures observed in more advanced idiopathic OA.
Method
PATIENTS
Institutional review board approval was obtained for the
collection of articular cartilages at surgery for ACL recon-
struction. Cartilage was removed from the mesial side of
the lateral condyle, as part of the surgical procedure. With
patient consent and institutional approval the cartilage
was saved. Some patients (nZ 28; median age 25 years,
range 14e46 years) underwent surgery within 1 year of joint
injury (median 2.5 months, range 1e10 months). Others
(nZ 22, median age 34 years, range 15e43 years) had
surgery at more than 1 year after injury (median 37.5, range
13e16 months).
Control cartilages were collected at autopsy from 21 per-
sons with a median age of 53 years, range 17e73 years.
TISSUE COLLECTION
Articular cartilages were frozen at 20(C within 1e2 h of
collection.
ANALYSES
Type II collagen, its cleavage and denaturation
Cartilages were digested with a-chymotrypsin and ana-
lysed for the type II collagen collagenase-generated car-
boxyterminal cleavage epitope recognized by antibody
COL2-3/4Cshort
7 and for the type II collagen intrachain epi-
tope recognized by monoclonal antibody COL2-3/4m to
determine the content of denatured type II collagen5. The
residual collagen and tissue components were digestedwith proteinase K and assayed for the remainder of the
COL2-3/4m epitope: the combination of these analyses
with this antibody is a measure of total tissue type II colla-
gen content5. As we have previously described5, the condi-
tions of digestion with a-chymotrypsin and proteinase K are
carefully controlled with inhibitors to prevent activation of
proteinases such as collagenases, which might be acti-
vated and digest collagen during the extraction. We have
previously shown5,7 that these proteinases do not destroy
the epitopes that are being extracted for assay. As before,
we presented the results for collagen cleavage and dena-
turation as a percentage of the total type II collagen content
to address the variable content of type II collagen found in
these cartilages.
Proteoglycan/glycosaminoglycan content
Both a-chymotrypsin and proteinase K digests were as-
sayed for glycosaminoglycan (GAG) content (principally
a measure of the proteoglycan aggrecan) using the dime-
thylmethylene blue assay18.
DNA content
This was determined in the proteinase K digest with a ﬂuo-
rometric method that uses the dye bisbenzimide (Hoechst
33258, Frankfurt, Germany) with an excitation wavelength
of 356 nm and an emission wavelength of 458 nm19.
Statistics
Comparisons between groups were made using Manne
Whitney analyses. Spearman rank linear regression analy-
ses were used for comparisons between different analyses
of the same samples. P! 0.05 is considered signiﬁcant.
Histology
Frozen sections of articular cartilage specimens obtained
at surgery and autopsy were ﬁxed, frozen sectioned and
stained with safranin O and fast green and analysed, as
we have described20 for degeneration using the Mankin
grading system21.
RESULTS
Histology
An examination of stained frozen sections of articular car-
tilages at autopsy, at less than 1 year post-ACL injury and at
more than 1 year after injury [Fig. 1(rows a, b, c)], revealed
that control cartilages were characterized by an intact artic-
ular surface but exhibited less safranin O stain for proteo-
glycan than is normally observed in healthy femoral
condylar cartilage remote from this site20. Staining was usu-
ally observed in the mid and deep zones but not close to the
articular surface.
Within a year of injury all specimens resembled the con-
trols in that the articular surface was usually intact, although
evidence of ‘‘pannus’’ tissue was sometimes seen
[Fig. 1(row c)]. Total loss of safranin O stain was also
seen in some cases [Fig. 1(row c)].
One year after ACL injury disruption of the articular sur-
face was more often noted [Fig. 1(rows a, b)]. In some
cases, lysis of matrix was seen in pericellular sites nearer
the articular surface [Fig. 1(row a)] and chondrocyte cloning
was observed [Fig. 1(row b)]. In general, safranin O stain
116 F. Nelson et al.: Cartilage degeneration following joint injuryFig. 1. Fixed frozen 6 mm sections of articular cartilage stained with safranin O and fast green to show three representative examples of car-
tilage histology from controls (autopsy), at less than 1 year and at more than 1 year following ACL injury. The time periods post-ligament rup-
ture are indicated in months under each panel. Ages are shown in brackets and sexes, male (M) and female (F). The articular surface is shown
in the upper part of each micrograph. The scales represent 100 mm.was reduced [Fig. 1(rows b, c)] or almost absent [Fig. 1(row
a)] after 1 year.
Analyses by Mankin grading of all available specimens
that were obtained for histology (Table I) revealed that the
‘‘normal’’ cartilages had a Mankin grade, with a mean of
3.9, that was higher than that (w1.0) observed in analyses
of femoral condylar cartilages from an older population20.
Comparing the cartilages from ACL injured joints to the con-
trols there were no signiﬁcant differences in grading ob-
served following ligament rupture although a trend was
noted that revealed an increase in grade from 3.9 (control)
through 4.3 (!1 year) to 5.1 which was observed after 1
year.
Table I
Mankin grading of histology
Controls (nZ 8) Post-ACL injury
!1 year (nZ 12) O1 year (nZ 8)
3.9G 1.5 4.3G 2.0 5.1G 2.0
MeanG SDs are shown for the number (n) of patients indicated.Matrix composition and degradation: changes
following ACL injury
In this study we only had access to control patients who
were, in general, older (median 53 years) than those who ex-
perienced ACL injury (group medians 25 and 34 years). We
have not, however, observed from other studies any evi-
dence of changes in collagen and proteoglycan contents
nor in collagen cleavage and denaturation in ageing human
knee condylar cartilages (A. R. Poole and A. Reiner, unpub-
lished) nor in ankle articular cartilages22.
The GAG and total type II collagen data were presented
per DNA since any tissue swelling might confound the inter-
pretation of data presented on a wet weight basis. The con-
tent of proteoglycan (GAG) varied considerably in some of
the control population [Fig. 2(a)]. In those patients exam-
ined less than 1 year post-ligament injury, the content
was signiﬁcantly increased over the control group with
a much greater range in content. Although the increase
and greater range of content persisted after 1 year it was
no longer signiﬁcantly elevated.
Type II collagen contents of the control population were
often also variable [Fig. 2(b)]. Unlike proteoglycan, there
were no changes in content following ligament injury.
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Fig. 2. The contents of (a) GAG (principally proteoglycan aggrecan) and (b) type II collagen, (c) its cleavage by collagenase and (d) its de-
naturation in articular cartilages of controls and patients at surgery less than or more than 1 year following ACL injury. Median values and
statistically signiﬁcant differences (by ManneWhitney) are indicated.Although collagen content did not change, the percen-
tages of type II collagen that was cleaved by collagenase
or denatured were both signiﬁcantly elevated following liga-
ment injury at less than 1 year and more than 1 year post-
injury [Fig. 2(c, d)].
Interrelationship of changes
To determine whether any of these changes were interre-
lated, the data were examined using Spearman correlation
analyses. In the control cartilages and in those at less than
1 year and at more than 1 year after injury there was a sig-
niﬁcant direct correlation between proteoglycan (GAG) and
total collagen contents [Fig. 3(c, d, e)]. After 1 year of injury
total type II collagen content was inversely correlated with
the percentage cleaved [Fig. 3(a)] and denatured
[Fig. 3(b)] type II collagen. The only other correlation, which
was weak, was between percentage cleaved and percent-
age denatured type II collagen that was seen after 1 year
[Fig. 3(f)].
Discussion
From analyses of synovial ﬂuids, Lohmander et al.14e17
have provided clear evidence for increased turnover of
the cartilage proteoglycan aggrecan and type II collagen
within days and weeks following joint injuries of this kind.
These alterations persist for years and are frequently asso-
ciated with the development of post-traumatic OA that is
commonly observed following knee joint injury.Our present study provides new and more direct evi-
dence for early histological and more deﬁnitively molecular
changes involving the increased cleavage of type II colla-
gen and increased proteoglycan in articular cartilage adja-
cent to the ACL following injury to this ligament. These
same changes have clearly been shown to be associated
with idiopathic OA and the development of experimental
OA following ACL rupture (see Introduction). The ﬁndings
extend earlier human work that revealed an increased
denaturation and loss of type II collagen following ACL
rupture23. They reveal the involvement of increased colla-
genase activity and conﬁrm the increase in increased col-
lagen denaturation in this pathology evidence for which
has been obtained from experimental studies of ACL rup-
ture24e27. They also reveal that an early transient increase
in proteoglycan content is also seen in human pathology as
well as in experimental studies of ACL injury13. They also
demonstrate that the increased denaturation and cleavage
seen after 1 year exhibit a clear inverse correlation with
type II collagen content although the latter was not detect-
ably reduced. Moreover, in experimental models of OA
involving ACL transection in the rat26 and the rabbit27, evi-
dence for increases in type II collagen denaturation and
cleavage were also observed in articular cartilage using
the antibodies we describe here. Together these experi-
mental investigations indicate the value of animal OA mod-
els involving ACL section in studying human disease.
The present results provide a molecular explanation for
why ACL injury so often progresses to clinically deﬁned
post-traumatic OA2. They provide direct evidence for the
rapid development of degenerative changes characteristic
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Fig. 3. Spearman rank linear regression analyses to show signiﬁcant interrelationships between GAG, type II collagen denaturation, content
and cleavage. Correlation coefﬁcients (r) and signiﬁcance (P) and the time from injury (! or O1 year) are shown.of OA following ACL injury. Because the time of injury is
known, this study enables us to determine the longitudinal
progression of cartilage degeneration in the human. In
view of other studies23 it would seem that these pathologi-
cal changes would not be restricted to articular cartilage ad-
jacent to the ACL insertion site but would in due course
progressively involve the whole joint.
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